A groundbreaking discovery in HIV immunology reveals that HIV-1 infection can trigger CD4+ T cells to express CD8+ markers while maintaining their HLA class II recognition capabilities—a biological phenomenon previously considered impossible. This unprecedented cellular conversion challenges foundational concepts in T cell lineage development that have guided immunological research for decades. The research team, working with multiple cohorts of HIV-positive patients, documented that converted cells retain functional immune memory despite their altered phenotype, suggesting a sophisticated mechanism of viral immune manipulation. Unlike conventional CD8+ cytotoxic T cells that recognize HLA class I molecules, these converted cells maintain their original specificity patterns, creating a unique hybrid cellular population. This unexpected plasticity in T cell biology could fundamentally reshape how researchers approach HIV treatment strategies and explain long-standing clinical observations about immune recovery in antiretroviral-treated patients. Read the full article on GMJ Newsroom.
Was this article helpful?
